Production (Stage)
Autolus Therapeutics plc
AUTL
$1.54
$0.010.65%
NASDAQ
03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 516.58M | 588.02M | 657.07M | 705.94M | 758.53M |
Total Receivables | 65.34M | 48.24M | 43.28M | 37.99M | 31.97M |
Inventory | 14.65M | 4.14M | -- | -- | -- |
Prepaid Expenses | 13.72M | 15.21M | 14.06M | 11.87M | 11.13M |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | 5.49M | 5.32M | 3.71M | 2.80M | 2.68M |
Total Current Assets | 615.77M | 660.93M | 718.11M | 758.60M | 804.30M |
|
|||||
Total Current Assets | 615.77M | 660.93M | 718.11M | 758.60M | 804.30M |
Net Property, Plant & Equipment | 114.22M | 105.05M | 104.76M | 90.54M | 92.54M |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | 12.48M | 12.37M | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | 3.87M | 4.37M | 4.62M | 4.48M | 4.60M |
Total Assets | 746.34M | 782.73M | 827.49M | 853.62M | 901.44M |
|
|||||
Total Accounts Payable | 4.46M | 1.97M | 1.42M | 1.10M | 1.40M |
Total Accrued Expenses | 47.28M | 51.80M | 47.09M | 35.20M | 37.20M |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | 2.97M | 3.00M | 3.57M | 4.23M | 4.82M |
Total Finance Division Other Current Liabilities | 11.90M | 3.98M | 403.00K | 382.00K | 570.00K |
Total Other Current Liabilities | 11.90M | 3.98M | 403.00K | 382.00K | 570.00K |
Total Current Liabilities | 66.62M | 60.74M | 52.47M | 40.90M | 43.99M |
|
|||||
Total Current Liabilities | 66.62M | 60.74M | 52.47M | 40.90M | 43.99M |
Long-Term Debt | 253.44M | 244.60M | 248.94M | 238.66M | 228.49M |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | 54.73M | 49.63M | 48.66M | 45.79M | 46.52M |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | 444.00K | 426.00K | 447.00K | 415.00K | 409.00K |
Total Liabilities | 375.23M | 355.40M | 350.53M | 325.78M | 319.41M |
|
|||||
Common Stock & APIC | 1.56B | 1.56B | 1.55B | 1.55B | 1.54B |
Retained Earnings | -1.17B | -1.10B | -1.07B | -989.52M | -931.25M |
Treasury Stock & Other | -17.99M | -29.06M | -780.00K | -27.79M | -28.82M |
Total Common Equity | 371.11M | 427.33M | 476.97M | 527.84M | 582.03M |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | 371.11M | 427.33M | 476.97M | 527.84M | 582.03M |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | 371.11M | 427.33M | 476.97M | 527.84M | 582.03M |
|